IRIS
MISSALE, Gabriele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.647
AS - Asia 5.102
EU - Europa 3.730
SA - Sud America 938
AF - Africa 298
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.730
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.502
SG - Singapore 2.212
CN - Cina 1.525
IE - Irlanda 826
BR - Brasile 787
IT - Italia 711
SE - Svezia 666
HK - Hong Kong 492
DE - Germania 380
VN - Vietnam 248
NL - Olanda 220
FR - Francia 217
ZA - Sudafrica 210
FI - Finlandia 207
TR - Turchia 178
RU - Federazione Russa 107
IN - India 100
CA - Canada 88
GB - Regno Unito 87
UA - Ucraina 74
AR - Argentina 66
AT - Austria 61
KR - Corea 60
BD - Bangladesh 45
JP - Giappone 42
CI - Costa d'Avorio 39
MX - Messico 37
IQ - Iraq 33
BE - Belgio 31
PL - Polonia 30
ID - Indonesia 26
CZ - Repubblica Ceca 21
CO - Colombia 19
PK - Pakistan 19
ES - Italia 18
EC - Ecuador 17
UZ - Uzbekistan 16
VE - Venezuela 16
LT - Lituania 14
MA - Marocco 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
CL - Cile 10
KE - Kenya 10
PY - Paraguay 10
RO - Romania 10
DK - Danimarca 8
EG - Egitto 8
IR - Iran 8
KH - Cambogia 7
KZ - Kazakistan 7
AU - Australia 6
CH - Svizzera 6
MY - Malesia 6
PE - Perù 6
TW - Taiwan 6
DZ - Algeria 5
EU - Europa 5
IL - Israele 5
LU - Lussemburgo 5
PA - Panama 5
TH - Thailandia 5
AM - Armenia 4
DO - Repubblica Dominicana 4
LV - Lettonia 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
EE - Estonia 3
GR - Grecia 3
JO - Giordania 3
KG - Kirghizistan 3
LB - Libano 3
OM - Oman 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
QA - Qatar 3
UY - Uruguay 3
AL - Albania 2
BN - Brunei Darussalam 2
GE - Georgia 2
HU - Ungheria 2
KW - Kuwait 2
LY - Libia 2
NP - Nepal 2
RS - Serbia 2
SI - Slovenia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TZ - Tanzania 2
AD - Andorra 1
AO - Angola 1
BB - Barbados 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
Totale 15.710
Salva come PNG Salva come JPEG
Città #
Singapore 1.062
Dublin 826
Ashburn 777
Chandler 620
Dallas 553
Santa Clara 542
Hong Kong 484
Beijing 388
Parma 222
Boardman 214
Ann Arbor 201
Johannesburg 198
Dearborn 191
Shanghai 171
Princeton 147
New York 142
Izmir 131
Nanjing 119
Munich 115
Los Angeles 114
Wilmington 99
Hefei 88
Ho Chi Minh City 85
São Paulo 83
Grafing 77
Helsinki 72
Jacksonville 69
Milan 68
Columbus 63
Hanoi 60
Moscow 59
Jinan 55
Seoul 54
Shenyang 51
Vienna 48
Des Moines 47
Bremen 43
Seattle 41
Tokyo 40
Abidjan 39
Chicago 36
Turku 36
Toronto 34
The Dalles 33
Tianjin 33
Hebei 32
Bengaluru 31
Kunming 31
Rome 31
Guangzhou 30
Kocaeli 30
Bologna 29
Frankfurt am Main 29
Rio de Janeiro 29
Nanchang 28
Nuremberg 28
Council Bluffs 27
Warsaw 25
Changsha 24
Brooklyn 23
Brussels 23
Montreal 23
Redmond 23
Ardea 22
Stockholm 22
Jakarta 21
Belo Horizonte 20
Jiaxing 20
Zhengzhou 20
Buffalo 19
Phoenix 19
Norwalk 18
San Mateo 18
London 17
Reggio Emilia 17
Düsseldorf 16
Chennai 15
Fairfield 15
Fremont 15
Hangzhou 15
Woodbridge 15
Salvador 14
Denver 13
Falls Church 13
Houston 13
Amsterdam 12
Atlanta 12
Haiphong 12
Mexico City 12
San Francisco 12
Tashkent 12
Baghdad 11
Baku 11
Boston 11
Dhaka 11
Istanbul 11
Manchester 11
Marseille 11
Montespertoli 11
Brno 10
Totale 9.673
Salva come PNG Salva come JPEG
Nome #
Role of immunoglobulin G fragment C receptor polymorphism-mediatedantibody-dependant1. cellular cytotoxicity in colorectal cancer treated withcetuximab therapy. Pharmacogenomics J. 250
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 247
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 224
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 222
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 195
Ammonium Production and Glutamine-Addiction of Myeloma Cells: New Attractive Targets in Multiple Myeloma 182
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target 176
A simplified sars-cov-2 pseudovirus neutralization assay 167
The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC 155
CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells 144
Metabolic regulation of the HBV-specific T cell function 139
Anti-Viral Intrahepatic T-Cell Responses can be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B 139
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 132
Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter 131
Activation of Natural Killer Cells During Acute Infection With Hepatitis C Virus 130
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma 126
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report 126
DEPENDENCE ON GLUTAMINE UPTAKE OF MYELOMA CELLS DELINEATES A NEW ATTRACTIVE THERAPEUTIC STRATEGY 126
Clinico-Immunological Profile of a 67-Year-Old Woman Affected by HER2-Positive Breast Cancer and Autoimmune Dermatomyositis 126
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 125
Are Anti-TNF-α Agents Safe for Treating Psoriasis in Hepatitis C Virus Patients with Advanced Liver Disease? Case Reports and Review of the Literature 124
Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells (Frontiers in Oncology, (2022), 12, (942341), 10.3389/fonc.2022.942341) 124
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 123
Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-reactivity and immune-mediated sequence variation 123
Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients 120
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 119
Role of immunoglobulin G fragment C receptor polymorphism-mediated antibody-dependant cellular cytotoxicity in colorectal cancer treated with cetuximab therapy 119
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 118
[68Ga]Nivolumab: a novel PET tracer to detect PD-1 expressing tumors 118
Ex vivo characterization of tumor-derived melanoma antigenencoding gene-specific CD8 1 cells in patientswith hepatocellular carcinoma 117
Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts 117
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 116
Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma 116
Correlation between LDH levels and response to sorafenib in HCC patients: An analysis of the ITA.LI.CA database 115
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 115
T cell regulation in HBV-related chronic liver disease 115
L-Asparaginase and Inhibitors of Glutamine Synthetase DiscloseGlutamine Addiction of Beta-Catenin-Mutated Human HepatocellularCarcinoma Cells 114
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 114
HBV immune-therapy: From molecular mechanisms to clinical applications 113
Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. 113
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 111
Antibody responses to hepatitis C virus hypervariable region 1: Evidence for cross-reactivity and immune-mediated sequence variation 111
Circulating immune-profile as predictor of outcome in advanced NSCLC patients treated with Nivolumab 111
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 108
Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines 107
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancer 104
Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient 102
Neoplastic macrovascular invasion represents an independent risk factor for dismal survival in sorafenib treatment for hepatocellular carcinoma 100
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment 100
The evolutionary scenario of hepatocellular carcinoma in Italy: an update 99
Clinical and hematologic parameters address the outcomes of non-small-cell lung cancer patients treated with nivolumab 99
The changing scenario of hepatocellular carcinoma in Italy: an update 99
Immune gene expression profile in hepatocellular carcinoma and surrounding tissue predicts time to tumor recurrence 98
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: A multicentre study 98
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 98
Infection of circulating and liver infiltrating T cells by hepatitis C virus of different subtypes 95
Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychologial follow-up 95
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group 94
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 94
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 93
Fine specificity of the human T cell response to hepatitis B virus core antigen 93
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics 92
COMPOSTO E COMPOSIZIONE PER IL RIPRISTINO METABOLICO E FUNZIONALE DEI LINFOCITI NK NELL’EPATOCARCINOMA E RELATIVO METODO 91
Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. 91
Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu-Positive Metastatic Breast Cancer. 91
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use 90
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 90
Etanercept in the treatment of psoriasis and psoriathic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients 90
Cytotoxic T Cell response to Melanoma Associated Antigens (MAGE) in patients with Hepatocellular Carcinoma. 90
TRANSCRIPTOME ANALYSIS OF EXHAUSTED VIRUS-SPECIFIC CD8 T CELLS IN CHRONIC HBV INFECTION IDENTIFIES PROFOUND METABOLIC AND FUNCTIONAL CELL DEFECTS 90
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 89
Oral lichen planus infiltrating T-cells:a Pathogenetic role for HCV-specific T cell responses? 89
Immunoglobulin G fragment C receptor polymorphisms and response to trastuzumab-based treatment in patients with HER-2/NEU-positive metastatic breast cancer 89
Immune pathogenesis of hepatitis B 88
AISF position paper on HCV in immunocompromised patients 88
Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV 88
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 88
[Surgical risks for cirrhotic patients] 88
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 87
Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial 87
The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro 86
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 85
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 85
Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein 85
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen 85
Role of viral and host factors in HCV persistence: Which lesson for therapeutic and preventive strategies? 84
Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma 84
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 83
Impact of Soluble CD26 on Treatment Outcome and Hepatitis C Virus-Specific T Cells in Chronic Hepatitis C Virus Genotype 1 Infection 83
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 82
In reply 81
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 79
High ASCT2 activity as a marker of extracellular glutamine dependence in ammoniagenic multiple myeloma cell lines 79
Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection 79
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 79
IMMUNE ESCAPE OF HEPATIC AND GASTROINTESTINAL CANCER:SECRETION OF SOLUBLE COMPLEMENT INHIBITORS 78
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments 78
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 78
Comparative pathogenesis of HBV and HCV 77
Nitrogen balance in the assessment of cirrhotic patients 77
Totale 11.047
Salva come PNG Salva come JPEG
Categoria #
all - tutte 65.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.653
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021551 0 0 0 0 51 53 72 72 144 70 54 35
2021/2022727 19 21 26 53 47 91 38 54 36 21 44 277
2022/20232.802 318 250 185 172 168 298 53 157 988 25 116 72
2023/20241.260 72 122 42 57 113 292 85 88 46 74 92 177
2024/20254.417 91 221 279 233 492 548 224 198 576 421 361 773
2025/20264.465 830 877 1.142 850 766 0 0 0 0 0 0 0
Totale 16.029